A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3 Randomized Controlled Trials (UP-AA)

Preview text: LearnSkin MasterClass A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3…

Thursday, Oct 15, 2026 at 5:04 AM EasternActiveCampaign

Integrative Dermatology SymposiumA JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3 Randomized Controlled Trials (UP-AA)

Fit to screenFull size

Using this email in an article? Credit: Integrative Dermatology Symposium email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3 Randomized Controlled Trials (UP-AA)
Preview text: LearnSkin MasterClass A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3…
From: info@learnskin.com
Brand: Integrative Dermatology Symposium
ESP: ActiveCampaign
Sent: Thu Oct 15, 2026, 5:04 AM ET
Size: 37 KB
Images: 9
Links: 9, 2 of them buttons
Subject length: 103 characters

Against Integrative Dermatology Symposium's usual

Sent in its busiest hour, 5 AM, which holds 77% of its emails. The subject is 103 characters; its average is 59.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: LearnSkin Webinars <[email protected]>
Subject: A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3 Randomized Controlled Trials (UP-AA)
Date: Thu, 15 Oct 2026 09:04:11 +0000 (GMT)
Message-ID domain: service-v2-59cfbb986c-k7zhc
Return-Path domain: em-727738.learnskin.com
DKIM signature: d=learnskin.com s=acdkim1; d=acems3.com s=acdkim1
Authentication: dkim=pass (learnskin.com), dkim=pass (acems3.com), spf=pass (em-727738.learnskin.com), dmarc=pass (learnskin.com)
List-Unsubscribe: Present, one-click
Mailer: ActiveCampaign Mailer
Feedback-ID sender: activecampaign

from mail135.use2.acems3.com [52.128.44.135] by our receiving server with ESMTPS
from (unnamed) by acems1.com with ESMTPS

Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid

	Oct 23, 2026 7:54 AM	Join Iltefat Hamzavi, MD for a LearnSkin Webinar: Essential TrutHS About HS: Deepening Knowledge and Elevating Patient Care
	Oct 21, 2026 6:03 AM	A JAK inhibitor in Nonsegmental Vitiligo: Results of Two Phase 3 Randomized Controlled Studies (Viti-Up)
	Oct 19, 2026 5:08 AM	October Is Moving Fast at LearnSkin
	Oct 15, 2026 5:04 AM	A JAK inhibitor in Severe Alopecia Areata: Results of Two Phase 3 Randomized Controlled Trials (UP-AA) (this email)
	Oct 6, 2026 5:03 AM	Join Dr Diego Dasilva for a LearnSkin Webinar: Expanding the Story in Moderate AD Patients With Higher Disease Severity
	Oct 5, 2026 5:05 AM	What’s Next for Your Learning This October?
	Sep 26, 2026 6:04 AM	Earn Up to 10 FREE CME Credits: Enhance Clinical Competence in Integrative Psoriasis Management